Identification of Potential Reference mirna for qrt-pcr Studies in Cancers Using mirna-seq Data

Similar documents
Patnaik SK, et al. MicroRNAs to accurately histotype NSCLC biopsies

On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles

High AU content: a signature of upregulated mirna in cardiac diseases

Validation of Housekeeping Genes for Gene Expression Analysis in Glioblastoma Using Quantitative Real-Time Polymerase Chain Reaction

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

Introduction to Systems Biology of Cancer Lecture 2

omiras: MicroRNA regulation of gene expression

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

micrornas (mirna) and Biomarkers

Session 4 Rebecca Poulos

From reference genes to global mean normalization

Human breast milk mirna, maternal probiotic supplementation and atopic dermatitis in offsrping

Obstacles and challenges in the analysis of microrna sequencing data

RNA-Seq profiling of circular RNAs in human colorectal Cancer liver metastasis and the potential biomarkers

RASA: Robust Alternative Splicing Analysis for Human Transcriptome Arrays

Deploying the full transcriptome using RNA sequencing. Jo Vandesompele, CSO and co-founder The Non-Coding Genome May 12, 2016, Leuven

genomics for systems biology / ISB2020 RNA sequencing (RNA-seq)

Small RNA Sequencing. Project Workflow. Service Description. Sequencing Service Specification BGISEQ-500 SERVICE OVERVIEW SAMPLE PREPARATION

developing new tools for diagnostics Join forces with IMGM Laboratories to make your mirna project a success

STAT1 regulates microrna transcription in interferon γ stimulated HeLa cells

MicroRNA and Male Infertility: A Potential for Diagnosis

micro-rnas as biomarkers in children who underwent surgery for CHD

A novel and universal method for microrna RT-qPCR data normalization

Post-transcriptional regulation of an intronic microrna

Screening for novel oncology biomarker panels using both DNA and protein microarrays. John Anson, PhD VP Biomarker Discovery

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL

Session 4 Rebecca Poulos

Personalized Therapy for Prostate Cancer due to Genetic Testings

microrna analysis for the detection of autologous blood transfusion in doping control

microrna Presented for: Presented by: Date:

Paternal exposure and effects on microrna and mrna expression in developing embryo. Department of Chemical and Radiation Nur Duale

Supplementary Figure 1

Identification of mirnas in Eucalyptus globulus Plant by Computational Methods

Evaluation of the performance of serum mirnas as normalizers in microrna studies focused on cardiovascular disease

Milk micro-rna information and lactation

Raymond Auerbach PhD Candidate, Yale University Gerstein and Snyder Labs August 30, 2012

Expression of mir-146a-5p in patients with intracranial aneurysms and its association with prognosis

RNA-seq Introduction

Supplementary information

microrna analysis Merete Molton Worren Ståle Nygård

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

HALLA KABAT * Outreach Program, mircore, 2929 Plymouth Rd. Ann Arbor, MI 48105, USA LEO TUNKLE *

RNA SEQUENCING AND DATA ANALYSIS

The value of Omics to chemical risk assessment

Deciphering the Role of micrornas in BRD4-NUT Fusion Gene Induced NUT Midline Carcinoma

The Cancer Genome Atlas & International Cancer Genome Consortium

Title: Dysregulated mir-183 Inhibits Migration in Breast Cancer

BIMM 143. RNA sequencing overview. Genome Informatics II. Barry Grant. Lecture In vivo. In vitro.

Introduction. Introduction

Analysis of small RNAs from Drosophila Schneider cells using the Small RNA assay on the Agilent 2100 bioanalyzer. Application Note

MicroRNA in Cancer Karen Dybkær 2013

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

Supplementary Data. (continued)

mirna in Plasma Exosome is Stable under Different Storage Conditions

Transcriptional control in Eukaryotes: (chapter 13 pp276) Chromatin structure affects gene expression. Chromatin Array of nuc

Extracellular Vesicle RNA isolation Kits

Lombardi Cancer Center Georgetown University Washington, DC

Cancer Problems in Indonesia

Study of mirna based gene regulation involved in Squamous Lung Carcinoma by assistance of Argonaute Protein

The Cancer Genome Atlas

MicroRNA-92gene expression in epithelial ovarian cancer using a novel Real-Time Polymerase change reaction

File Name: Supplementary Information Description: Supplementary Figures and Supplementary Tables. File Name: Peer Review File Description:

CURRICULUM VITA OF Xiaowen Chen

ExpressArt FFPE Clear RNAready kit

Simple, rapid, and reliable RNA sequencing

Supplementary Materials for

Package TargetScoreData

University of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant

Ambient temperature regulated flowering time

IDENTIFICATION OF IN SILICO MIRNAS IN FOUR PLANT SPECIES FROM FABACEAE FAMILY

SUPPLEMENTARY INFORMATION. Supp. Fig. 1. Autoimmunity. Tolerance APC APC. T cell. T cell. doi: /nature06253 ICOS ICOS TCR CD28 TCR CD28

SUPPLEMENTAL FILE. mir-22 and mir-29a are members of the androgen receptor cistrome modulating. LAMC1 and Mcl-1 in prostate cancer

Circular RNA_LARP4 is lower expressed and serves as a potential biomarker of ovarian cancer prognosis

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Analysis of paired mirna-mrna microarray expression data using a stepwise multiple linear regression model

Utility of Circulating micrornas in Cardiovascular Disease

A Practical Guide to Integrative Genomics by RNA-seq and ChIP-seq Analysis

Products for cfdna and mirna isolation. Subhead Circulating Cover nucleic acids from plasma

Supplementary Information

microrna PCR System (Exiqon), following the manufacturer s instructions. In brief, 10ng of

Identification of suitable reference genes for the relative quantification of micrornas in pleural effusion

Gene-microRNA network module analysis for ovarian cancer

MicroRNA-mediated incoherent feedforward motifs are robust

MicroRNAs: novel regulators in skin research

In Silico Analysis to Predict Structure, Sequence Motif and Expression Level of Breast Cancer Biomarker Molecules: Protein and mirna

A General Workflow to Analyze Key Cancer-Related Genes Based on NCBI illustrated by the case of gastric cancer

Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases

RECENT ADVANCES IN THE MOLECULAR DIAGNOSIS OF BREAST CANCER

Gene expression profiling in single cells

Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent Protein.

Genomic explorations have offered us a great deal. Buried Treasure

The Biology and Genetics of Cells and Organisms The Biology of Cancer

RNA interference induced hepatotoxicity results from loss of the first synthesized isoform of microrna-122 in mice

EPIGENOMICS PROFILING SERVICES

Regulation of Gene Expression in Eukaryotes

Small RNA existed in commercial reverse transcriptase: primary evidence of functional small RNAs

mirna Whole Transcriptome Assay

Original Article Up-regulation of mir-10a and down-regulation of mir-148b serve as potential prognostic biomarkers for osteosarcoma

Cellecta Overview. Started Operations in 2007 Headquarters: Mountain View, CA

Transcription:

International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 12 (2017) pp. 1327-1333 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.612.150 Identification of Potential Reference mirna for qrt-pcr Studies in Cancers Using mirna-seq Data Rajesh Kumar, Avinash Marwal and R.K. Gaur * Department of Biosciences, College of Arts, Science and Humanities, Mody University, Lakshmangarh, Sikar 332311, Rajasthan, India *Corresponding author A B S T R A C T K e y w o r d s TCGA, qrt-pcr, Reference mirna cancer. Article Info Accepted: 12 October 2017 Available Online: 10 December 2017 Quantitative real-time polymerase chain reaction (qrt-pcr) is a low cost, rapid, accurate method for quantification of gene expression. Accuracy of qrt-pcr expression quantification is highly dependable on selected reference genes or mirnas as these genes or mirnas work as internal controls for normalization to quantify expression among different. Problems have been reported with steady expression or stability of reference genes in various conditions. Thus suitable reference genes or mirnas need to be identified in various experimental conditions. The Cancer Genome Atlas (TCGA) Level 3 mirna expression data for 11 cancers were collected, after pre-processing data from 4 cancers having 102 normal and 1428 tumor was used to find potential reference mirna. Mean, coefficient of variation among normal and tumor were checked to find highly, stably expressed mirnas between normal and tumor conditions. We found 32 potential qrt-pcr reference mirnas in 3 out of 4 cancer types. 15 mirna were found in cholangiocarcinoma (CHOL), 13 mirna in kidney renal papillary cell carcinoma (KIRP) and 4 mirna in stomach and esophageal carcinoma (STES). We did not find any mirna passing all selection criteria in glioma (GBMLGG). In this study we used TCGA data to find potential qrt-pcr reference mirnas in 4 cancers. We performed computational analysis of 1530 expression profiles of both normal and tumor conditions from 4 human cancer types and found total 32 stably and highly expressed potential reference mirnas in 3 out of 4 cancer types. Data generated using next-generation sequencing (NGS) technologies can be very helpful in finding reference qrt-pcr mirnas. Introduction qrt-pcr is a very popular variant of PCR which is used for low cost, rapid and accurate expression quantification of transcripts. Gene expression quantification using qrt-pcr is done with the help of reference genes. These genes are used as internal controls to normalize and remove biases introduced by differences in RNA content extraction, transfer, storage, quantity and quality of RNA 1327 material, reverse transcriptional activity across different (Bustin et al., 2009). Reference genes are chosen for normalization based on their high and stable expression. Expression levels of reference genes don t vary much under different conditions, organisms, tissues and under study consideration. Most common reference genes are housekeeping genes such as GAPDH, 18s

rrna, ACTB, GUSB, HMBS, TBP etc. (Kozera and Rapacz, 2013). However ideally the expression of these references should be constitutively constantly high, and should not vary in different, nor be affected by experimental treatments, but in reality expression of the housekeeping genes or other most commonly used reference genes vary in different type of tissues, developmental stages, related species, abiotic stress, disease and infection, tumors and alternative splicing can also affect their expression (Glare et al., 2002; Kozera and Rapacz, 2013). Thus identification of reference genes or mirnas in various conditions is an important task in designing accurate and reliable qrt-pcr studies. Apart from selecting housekeeping gene or other commonly used genes as reference there has been lot of attempts to identify reference gene in various cell lines and experimental conditions (Frericks and Esser, 2008; Kwon et al., 2009; Lee et al., 2007; Popovici et al., 2009; Saviozzi et al., 2006). Due to arrival of latest reference gene free expression quantification technologies such as microarray and NGS the data generated by these machines can be used for reference gene selection in desired tissue/condition. Next generation sequencing technology variant such as RNA-seq has significantly reduced the cost and time of sequencing transcripts and is being used to generate gene expression data from various tissues and conditions. This data is being made publicly available by submitting it to online databases such as Gene Expression Omnibus (GEO) (Barrett et al., 2013), Sequence Read Archive (SRA) (Leinonen et al., 2011), TCGA (http://cancergenome.nih.gov/) etc. TCGA is one specialized database in storing NGS data generated from various cancer tissues. We performed computational analysis of 1530 from 4 human cancer conditions and found total 32 stably and highly expressed potential reference mirnas in 3 human cancer conditions. Further laboratory based validation will be required to find validity of these potential reference mirnas. Materials and Methods mirna expression data collection and preprocessing TCGA Level 3 mirna expression data generated using Illumina HiSeq platform for 11 cancers was collected from GDAC firehose website (https://gdac.broadinstitute. org/) in RPM format. GDAC firehose is a BROAD Institute s initiative to stores TCGA data in processed format. Cancers having 5 or more normal were included in the study. From all the collected 7 cancer types did not have expression data for normal conditions. Finally we chose 4 cancer having 102 normal and 1428 tumor for analysis. Expression data of 5p, 3p arm of mature mirna was taken in reads per million (RPM) format. Selection of potential reference mirnas Total 4 criteria were set to select potential reference mirnas. In this study, the definition of a reference mirna is a mirna that is highly and stably expressed across normal and tumor conditions. Potential reference mirna for each cancer type were filtered using the following criteria, based on previous studies. mirna should express in all. Thus it should have RPM expression value > 0 in all. 1328

Mean (N) > 100 and Mean (T) > 100. CV (N) < 0.5 and CV (T) < 0.5. Mean (N)/Mean (T) < 1.3 and Mean (T)/Mean (N) < 1.3. Results and Discussion To find potential qrt-pcr reference mirna, we used mirna-seq data from 4 cancer types more detail about number of total, tumor, normal are given in Table 1. Table 2 contains details about number of mirnas passing various criteria for selection of reference mirna as described in material and methods section. We found a total 32 reference mirna satisfying the criteria we set to identify potential reference mirnas in all 4 cancer types. Cholangiocarcinoma (CHOL) had 15 mirna, no mirna passed selection criteria in glioma (GBMLGG), kidney renal papillary cell carcinoma (KIRP) 13 mirna, stomach and esophageal carcinoma (STES) had 4 potential reference mirna. Names of potential reference mirna are given in Table 3. Mean RPM expression values of various potential reference mirna in different cancer conditions are plotted in Figure 1, 2 and 3. Many let-7 and hsa-mir-30 family mirnas showed stable expression in various conditions. hsa-mir-361-5p was also stably expressed in CHOL, KIRP which was also discovered by Zhan and colleagues (Zhan et al., 2014) in many other cancer types. Most commonly used reference genes for qrt-pcr studies such as several housekeeping genes and non-coding RNA such as 18s rrna are not suitable for expression quantification in all conditions due to inconsistency in their expression levels across tissue space and biological conditions (de Kok et al., 2005). Gene sequences are much lengthier as compared to mirna, making them unsuitable for mirna qrt-pcr expression quantification studies. Thus Careful selection of an appropriate reference is extremely important as no single reference gene can serve as a universal control for all experimental conditions. MicroRNAs are a class of small RNA molecules that regulate gene expression in many biological processes and disease conditions by mrna degradation, translational repression, RNA-directed DNA methylation (Bartel, 2004; Floyd and Bowman, 2005; Millar and Waterhouse, 2005). Reference mirna for normalization and the mirna being quantified should be from same type of sample for greater accuracy of expression quantification. Zhan et al., (2014) used TCGA mirna-seq data from 14 cancers having total 589 normal and 5727 tumor and identified total 126 potential reference mirnas. To extend their work and find suitable potential reference mirna, we investigated TCGA high throughput mirna-seq expression data from 4 cancer conditions. We identified 32 potential reference mirna in 3 cancer conditions. mirna such as let-7 family, hsa-mir-22 which showed highly stable expression is involved in various cancer suppression. These mirna are good for patient survival (Stahlhut Espinosa and Slack, 2006). Let-7 is known to be targeting tumorigenesis and angiogenesis and has also been reported as reference mirna in other studies (Chang et al., 2010). Apart from these hsa-mir-361-5p was also reported by Zhan (Zhan et al., 2014). 1329

Cancer type Table.1 Number of in each cancer tumor Number of normal Number of tumor Cholangiocarcinoma (CHOL) 9 36 45 Glioma (GBMLGG) 5 526 531 Kidney renal papillary cell carcinoma (KIRP) Stomach and Esophageal carcinoma (STES) Total 34 292 326 54 574 628 Table.2 Number of mirna in 4 cancer that passed our selection criteria as described in material and methods section Cancer Type Cholangiocarcinoma (CHOL) mirna having > 0 RPM in all Normal Tumor Stable in both normal and Highly Stable Highly tumor Expressed Expressed Stable 2195 123 99 125 40 39 15 Glioma (GBMLGG) 1786 157 88 114 9 7 0 Kidney renal papillary cell carcinoma (KIRP) 2004 115 64 111 25 22 13 Stomach and Esophageal carcinoma 1725 116 29 127 14 9 4 (STES) Cancer type Cholangiocarcinoma (CHOL) Table.3 Potential reference mirna identified in each cancer type Glioma (GBMLGG) - Kidney renal papillary cell carcinoma (KIRP) Stomach and Esophageal carcinoma (STES) Potential reference mirnas Potential reference mirna hsa-let-7a-5p, hsa-let-7d-5p, hsa-let-7d-3p, hsa-let-7f-5p, hsamir-15a-5p, hsa-mir-16-5p, hsa-mir-26a-5p, hsa-mir-29a-3p, hsa-mir-103a-3p, hsa-mir-197-3p, hsa-mir-30c-5p, hsa-mir- 145-5p, hsa-mir-186-5p, hsa-mir-361-5p, hsa-mir-151a-5p hsa-let-7a-5p, hsa-let-7d-3p, hsa-mir-24-3p, hsa-mir-30a-5p, hsa-mir-92a-3p, hsa-mir-101-3p, hsa-mir-30d-5p, hsa-let-7g- 5p, hsa-mir-23b-3p, hsa-mir-140-3p, hsa-mir-30e-5p, hsa-mir- 361-5p, hsa-mir-151a-3p hsa-mir-22-3p, hsa-mir-28-5p, hsa-mir-140-3p, hsa-mir-374a- 3p 1330

Fig.1 Mean RPM value plot of various potential reference mirnas in cholangiocarcinoma Fig.2 Mean RPM value plot of various potential reference mirnas in kidney renal papillary cell carcinoma Fig.3 Mean RPM value plot of various potential reference mirnas in stomach and esophageal carcinoma 1331

Highly expressed (as compared to other potential qrt-pcr reference mirna) both in normal and CHOL tumor cells, potential qrt- PCR reference mirna 5p arm of hsa-let-7a which is known to modulate interleukin-6- dependent STAT-3 survival signaling in malignant human cholangiocytes (Meng et al., 2007). Others were hsa-mir-103a-3p, hsa-let-7f-5p, hsa-mir-29a-3p. hsa-mir-30a- 5p and has-mir-22-3p were highly expressed mirna in KIRP and STES among other potential qrt-pcr reference mirna. Further experimental validation is necessary to use these mirna as control for expression quantification. Most commonly used reference genes and mirnas are not suitable as qrt-pcr reference mirna because their expression can vary among various conditions. Thus identification of qrt-pcr reference mirna becomes must to calculate expression using qrt-pcr. NGS technologies are reference free expression methods, thus can be utilized to find stably, highly expressed genes/mirnas across. In this study we analyzed TCGA mirna-seq data to find potential qrt-pcr reference mirnas for 4 cancer conditions. Total 32 potential qrt- PCR reference mirnas for 3 cancerous conditions were found. These mirnas must be validated in wet lab before their use. Acknowledgement The authors are thankful to Department of Biotechnology, New Delhi, India for providing financial assistance through Bioinformatics National Certification (BINC) (File No. PU/BINC/2016/E-04), Science and Engineering Research Board Department of Science and Technology, New Delhi, India for the financial assistance (File No. YSS/2015/000265). We would like to thank Mr. Purshotam Das for providing technical support while carrying out this research work. Competing interests Authors do not have any competing interests. Author s contributions Rajesh Kumar - Carried out the research work and wrote the manuscript. Avinash Marwal - Drafting the article and revising it critically R.K. Gaur - Corresponding author and final approval of the version to be published References Barrett, T., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., Tomashevsky, M., Marshall, K.A., Phillippy, K.H., Sherman, P.M., Holko, M., Yefanov, A., Lee, H., Zhang, N., Robertson, C.L., Serova, N., Davis, S., Soboleva, A., 2013. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 41, D991 D995. doi:10.1093/nar/gks1193 Bartel, D.P., 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281 297. Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J., Wittwer, C.T., 2009. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clin. Chem. 55, 611 622. doi:10.1373/clinchem.2008.112797 Chang, K.H., Mestdagh, P., Vandesompele, J., Kerin, M.J., Miller, N., 2010. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 10. doi:10.1186/1471-2407-10-173 De Kok, J.B., Roelofs, R.W., Giesendorf, B.A., Pennings, J.L., Waas, E.T., Feuth, T., Swinkels, D.W., Span, P.N., 2005. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab. 1332

Invest. 85, 154 159. doi:10.1038/labinvest. 3700208 Floyd, S.K., Bowman, J.L., 2005. MicroRNAs: Micro-managing the Plant Genome, in: Meyer, P. (Ed.), Plant Epigenetics. Blackwell Publishing Ltd, Oxford, UK, pp. 244 278. Frericks, M., Esser, C., 2008. A toolbox of novel murine house-keeping genes identified by meta-analysis of large scale gene expression profiles. Biochim. Biophys. Acta BBA - Gene Regul. Mech. 1779, 830 837. doi:10.1016/j.bbagrm.2008.08.007 Glare, E.M., Divjak, M., Bailey, M.J., Walters, E.H., 2002. beta-actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mrna levels. Thorax 57, 765 770. Kozera, B., Rapacz, M., 2013. Reference genes in real-time PCR. J. Appl. Genet. 54, 391 406. doi:10.1007/s13353-013-0173-x Kwon, M.J., Oh, E., Lee, S., Roh, M.R., Kim, S.E., Lee, Y., Choi, Y.-L., In, Y.-H., Park, T., Koh, S.S., Shin, Y.K., 2009. Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis. PLoS ONE 4, e6162. doi:10.1371/journal.pone.0006162 Lee, S., Jo, M., Lee, J., Koh, S.S., Kim, S., 2007. Identification of novel universal housekeeping genes by statistical analysis of microarray data. J. Biochem. Mol. Biol. 40, 226 231. Leinonen, R., Sugawara, H., Shumway, M., on behalf of the International Nucleotide Sequence Database Collaboration, 2011. The Sequence Read Archive. Nucleic Acids Res. 39, D19 D21. doi:10.1093/nar/gkq1019 Meng, F., Henson, R., Wehbe-Janek, H., Smith, H., Ueno, Y., Patel, T., 2007. The MicroRNA let-7a Modulates Interleukin-6- dependent STAT-3 Survival Signaling in Malignant Human Cholangiocytes. J. Biol. Chem. 282, 8256 8264. doi:10.1074/jbc. M607712200 Millar, A.A., Waterhouse, P.M., 2005. Plant and animal micrornas: similarities and differences. Funct. Integr. Genomics 5, 129 135. doi: 10.1007/s10142-005-0145-2 Popovici, V., Goldstein, D.R., Antonov, J., Jaggi, R., Delorenzi, M., Wirapati, P., 2009. Selecting control genes for RT-QPCR using public microarray data. BMC Bioinformatics 10, 42. doi: 10.1186/1471-2105-10-42 Saviozzi, S., Cordero, F., Iacono, M.L., Novello, S., Giorgio, S.V., Calogero, R.A., 2006. Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer 6. doi:10.1186/1471-2407-6-200 Stahlhut Espinosa, C.E., Slack, F.J., 2006. The role of micrornas in cancer. Yale J. Biol. Med. 79, 131 140. Zhan, C., Yan, L., Wang, L., Jiang, W., Zhang, Y., Xi, J., Chen, L., Jin, Y., Qiao, Y., Shi, Y., Wang, Q., 2014. Identification of reference mirnas in human tumors by TCGA mirna-seq data. Biochem. Biophys. Res. Commun. 453, 375 378. doi:10.1016/j. bbrc.2014.09.086. How to cite this article: Rajesh Kumar, Avinash Marwal and Gaur, R.K. 2017. Identification of Potential Reference mirna for qrt-pcr Studies in Cancers Using mirna-seq Data. Int.J.Curr.Microbiol.App.Sci. 6(12): 1327-1333. doi: https://doi.org/10.20546/ijcmas.2017.612.150 1333